
Parnika Antibiotics Private Limited
About Parnika Antibiotics Private Limited
Data last updated:
Parnika Antibiotics Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the brokerage and trading services segment of the financial services sector. It was incorporated on 05 August 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1988PTC048379.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sunita Ashokkumar Damani and Rajkumar Damani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.78 Lakh, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹23.1 Lakh (net margin 66.4%) and EBITDA of ₹34.54 Lakh (EBITDA margin 99.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 5% over five years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Parnika Antibiotics Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address10 Floor G Plot 10 Bandukwala Building British Hotel Lane Bombay Stock Exchang, E Fort, Mumbai, Maharashtra, India – 400001
- IndustryFinancial Services, Brokerage & Trading Services
To see the full contact details of Parnika Antibiotics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Parnika Antibiotics Private Limited
FY 2024 filings availableParnika Antibiotics Private Limited reported revenue of ₹34.78 Lakh (up 49% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 49% growth in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 99.3% | ||||
| Net Profit Margin | 66.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Parnika Antibiotics Private Limited, buy the company report.
Board of directors of Parnika Antibiotics Private Limited
Parnika Antibiotics has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunita Ashokkumar Damani Also directs: Anirudh Commodities Pvt Ltd, Lavolta Investments Private Limited, Artha Energy Resources LLP and 1 more | Director | 02 Jun 2021 | 5 Years 5 Months | Current |
| Rajkumar Damani Also directs: K. Damani Hospitality Private Limited, Vibhuti Traders Private Limited, Mahtab Investments and Finance Pvt Ltd and 4 more | Director | 05 Aug 1988 | 38 Years 3 Months | Current |
| Ashok Kumar Kishori Lal Damani Also directs: Artha Venture Partners LLP, Artha Singularity Venture Partners LLP, Arthawind Share Private Limited and 5 more | Director | 05 Aug 1988 | 38 Years 3 Months | Current |
Peer comparison
Parnika Antibiotics Private Limited is compared with the 8 companies closest to it by revenue in the BFSI industry (Broking Services), with the same principal business activity (other financial activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sar Organizers Private Limited | ₹34.93 Lakh (FY 2025) | -17.0% | Ahmedabad, Gujarat, India | |||
| Prudent Broking Services Private Limited | ₹34.9 Lakh (FY 2023) | -34.0% | Ahmedabad, Gujarat, India | |||
| Adilakshmi Finvest Private Limited | ₹34.79 Lakh (FY 2025) | 11.0% | Delhi, India | |||
| Parnika Antibiotics Private Limitedthis company | ₹34.78 Lakh (FY 2025) | ₹23.1 Lakh | 66.4% | 49.0% | Mumbai, Maharashtra, India | |
| Cardinal Broking Services Private Limited | ₹34.73 Lakh (FY 2025) | 44.0% | Mumbai, Maharashtra, India | |||
| Phoenix Share and Stockbrokers Private Limited | ₹34.72 Lakh (FY 2025) | 24.0% | Mumbai, Maharashtra, India | |||
| India Technology Investments Private Limited | ₹34.7 Lakh (FY 2024) | 42.0% | Mumbai, Maharashtra, India | |||
| Value Rock Broking Services Private Limited | ₹34.68 Lakh (FY 2025) | -92.0% | Mumbai, Maharashtra, India | |||
| Raman Commodities Private Limited | ₹34.61 Lakh (FY 2025) | 681.0% | Bathinda, Punjab, India |
To see the full peer comparison of Parnika Antibiotics Private Limited, buy the company report.
Auditor
Parnika Antibiotics Private Limited is audited by G.DAGA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.DAGA & CO | FY 2022 | 101990W |
Shareholding
The shareholding of Parnika Antibiotics Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Parnika Antibiotics Private Limited, buy the company report.
Legal cases
Parnika Antibiotics Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai Small Causes Court, Maharashtra | Court case (RAD) | Filed against the company by an individual | Disposed |
To see the full case history of Parnika Antibiotics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parnika Antibiotics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Parnika Antibiotics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Parnika Antibiotics Private Limited has 5 board changes on record since 1988: 3 appointments and 2 cessations. The latest: Sunita Ashokkumar Damani ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Parnika Antibiotics is an active private limited company based in Mumbai, Maharashtra, India. The company works in brokerage and trading services, within the financial services industry. It was incorporated on 05 August 1988 (38+ years old) and is registered under CIN U24230MH1988PTC048379.
Parnika Antibiotics has 3 current directors:
- Sunita Ashokkumar Damani - Director
- Rajkumar Damani - Director
- Ashok Kumar Kishori Lal Damani - Director
The latest financial statements of Parnika Antibiotics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Parnika Antibiotics is U24230MH1988PTC048379. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parnika Antibiotics has 1 court case on record: 1 filed against it.
Parnika Antibiotics was incorporated on 05 August 1988, making it 38+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Parnika Antibiotics by revenue are Sar Organizers Private Limited, Prudent Broking Services Private Limited, Adilakshmi Finvest Private Limited, Cardinal Broking Services Private Limited, Phoenix Share and Stockbrokers Private Limited and 3 more, all in the BFSI industry (Broking Services), with the same principal business activity (other financial activities).
Sunita Ashokkumar Damani ceased to be Additional Director on 30 Sep 2022. Sunita Ashokkumar Damani was appointed as Director on 02 Jun 2021. Suman Rajkumar Damani ceased to be Additional Director on 29 Sep 2017. Parnika Antibiotics has 5 board changes on record in total.
The registered office of Parnika Antibiotics is at 10 Floor G Plot 10 Bandukwala Building British Hotel Lane Bombay Stock Exchang, E Fort, Mumbai, Maharashtra, India – 400001.
Parnika Antibiotics operates in the financial services industry, in the brokerage and trading services segment.
The compliance status of Parnika Antibiotics is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.

